The European Medicines Agency (EMA) Thursday announced it had approved the use of Pfizer's anti-COVID-19 pill Paxlovid, which has thus become the first oral treatment cleared for use in the European Union. The new drug is a combination of the molecule PF-07321332 and the HIV antiviral Ritonavir.
European Commission President Ursula von der Leyen admitted this past weekend there was a growing interest in welcoming tourists from the United States.